These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 162424)

  • 41. Insulin therapy in patients with systemic insulin allergy.
    Mattson JR; Patterson R; Roberts M
    Arch Intern Med; 1975 Jun; 135(6):818-21. PubMed ID: 1130927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [On the determination of insulin antibodies].
    Mikhkla SK; Ivanova TS
    Probl Endokrinol Gormonoter; 1966; 12(2):63-8. PubMed ID: 4972241
    [No Abstract]   [Full Text] [Related]  

  • 43. Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.
    Irvine WJ; Al-Khateeb SF; Di Mario U; Feek CM; Gray RS; Edmond B; Duncan LJ
    Clin Exp Immunol; 1977 Oct; 30(1):16-21. PubMed ID: 606435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Measurement and clinical significance of insulin antibody and anti-insulin receptor antibody].
    Kobayashi M; Ishibashi O
    Rinsho Byori; 1985 May; 33(5):513-8. PubMed ID: 4057637
    [No Abstract]   [Full Text] [Related]  

  • 45. [Synthetic human insulin and diabetes mellitus: immunologic aspects].
    Guglielmi G; Ceccaroni P
    Clin Ter; 1984 Nov; 111(4):347-57. PubMed ID: 6396026
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of monocomponent insulin serum anti-insulin antibody levels (author's transl)].
    García de los Ríos M; Mella I; Durruty P; Ruiz F; López G; Tapia JC; González G
    Rev Med Chil; 1981 Jun; 109(6):509-15. PubMed ID: 7036310
    [No Abstract]   [Full Text] [Related]  

  • 47. Extreme insulin resistance: a consequence of insulin switching?
    Keenan WF; Abgott MA
    J Fam Pract; 1988 Dec; 27(6):635-6. PubMed ID: 3058859
    [No Abstract]   [Full Text] [Related]  

  • 48. [Insulin resistant diabetes].
    Imura H; Morimoto M; Kuzuya H
    Nihon Rinsho; 1971 Dec; 29(12):2962-9. PubMed ID: 5169010
    [No Abstract]   [Full Text] [Related]  

  • 49. Determination of anti-insulin activity by means of the complement fixation test.
    Kosmala U; Czarnowska J
    Pol Med J; 1967; 6(2):319-23. PubMed ID: 6030640
    [No Abstract]   [Full Text] [Related]  

  • 50. [Diabetes and immunology. III. Immunological reactions related to insulin treatment].
    Ekoe JM; Albert J
    Sem Hop; 1983 Jun; 59(23):1784-7. PubMed ID: 6308810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antibodies to insulin in patients with diabetes mellitus].
    Kozopolianskaia MM; Poltorak VV; Stetsenko KP
    Vrach Delo; 1973 Feb; 2():110-2. PubMed ID: 4722307
    [No Abstract]   [Full Text] [Related]  

  • 52. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study on the insulin-binding capacity of blood serum by a cellulose adsorption method.
    Baranyi E; Tamás G; Bojta J
    Acta Med Acad Sci Hung; 1975; 32(2):173-81. PubMed ID: 798462
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Difference in the pathogenesis of insulin-dependent and insulin-independent diabetes mellitus].
    Spanár E; Záhradný V; Uhrín P; Levcík A
    Vnitr Lek; 1974 Oct; 20(10):961-6. PubMed ID: 4420447
    [No Abstract]   [Full Text] [Related]  

  • 55. [Insulin antibodies in untreated and insulin-treated diabetics].
    Ditsov S; Penchev I; Andreev D; Sirakov L; Turkolev N
    Vutr Boles; 1972; 11(3):95-9. PubMed ID: 4679989
    [No Abstract]   [Full Text] [Related]  

  • 56. Heterogeneity and specificity of human anti-insulin antibodies determined by isoelectric focusing.
    Thomas JW; Virta VJ; Nell LJ
    J Immunol; 1985 Feb; 134(2):1048-52. PubMed ID: 3880786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Fatty diabetes, insulin resistance and anti-insulin antibodies].
    Jacotot B; Navarro N; Delplanque B; Le Parco JC; Beaumont JL
    Nouv Presse Med; 1973 Apr; 2(17):1121-4. PubMed ID: 4707009
    [No Abstract]   [Full Text] [Related]  

  • 58. Humoral immunity in type 1 diabetes mellitus: a prospective study.
    Borsey DQ; Di Mario U; Irvine WJ; Gray RS; Guy K; Weston J; Peutherer J; Duncan LJ
    J Clin Lab Immunol; 1983 May; 11(1):9-15. PubMed ID: 6876143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Insulin resistant diabetes mellitus--with special reference to insulin antibody].
    Nihon Rinsho; 1970 Oct; 28(10):2541-6. PubMed ID: 5529051
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter: Antigenicity of "monocomponent" insulins.
    Yue DK; Turtle JR
    Lancet; 1974 Oct; 2(7887):1022. PubMed ID: 4138266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.